## Abstract It was previously observed that MOPC‐315EL, a subline of the BALB/c myeloma tumor MOPC‐315, varies in its ability to interact with primary anti‐H‐2^d^ cytotoxic thymus‐derived lymphocytes (CTL) while remaining invariant in its expression of cell surface antigens recognized by anti‐H‐2^d
Lysis of enucleated tumor cells with allogeneic and syngeneic cytotoxic thymus-derived lymphocytes
✍ Scribed by Arthur H. Hale; Leslie K. Paulus
- Publisher
- John Wiley and Sons
- Year
- 1979
- Tongue
- English
- Weight
- 726 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
These studies were initiated to understand the minimal requirements for lysis of target cells by cytotoxic thymus‐derived lymphocytes (CTL). In particular, the significance of the nucleus to the susceptibility of the target cell to be lysed by CTL have been studied. P815 mastocytoma cells and EL4 lymphoma cells were enucleated by cen‐ trifugation through a discontinuous Ficoll gradient containing 10 μg/ml of cytochalasin B. The resultant vesicles were then analyzed for susceptibility to lysis by different CTL specific for the H‐2K and H‐2D gene products, minor histocompatibility antigens, trinitrophenyl groups, and Sendai virus‐specific antigens. The results indicate that enucleated vesicles obtained from both EL 4 and P 815 cells are susceptible to lysis by these CTL. The lysis of EL 4‐enucleated vesicles (unlike P 815‐enucleated vesicles), however, required 2–4 times more effector cells than were required for equivalent lysis of intact EL 4 cells. This reduced susceptibility to lysis of enucleated EL 4 vesicles was not the result of an inability of the CTL to recognize and bind the vesicles. This conclusion was suggested by the fact that both enucleated EL 4 vesicles and intact cells inhibited equally well the lysis of ^51^Cr‐labeled concanavalin A‐stimulated BALB. B spleen cells by anti‐H‐2^b^ CTL. Although enucleated vesicles obtained from both P 815 and EL 4 cells were susceptible to lysis by CTL, they exhibited a reduced capacity to “cap” their serologically defined H‐2 antigens.
Lysis of these enucleated vesicles by CTL has the same requirements as lysis of intact cells. This conclusion was based upon the requirement for Ca^++^ and Mg^++^ and also because lysis of the modified vesicles (trinitrophenyl or viral antigens) occurred in an H‐2‐restricted fashion. Moreover, the enucleated vesicles were susceptible to antibody and complement‐mediated lysis and also lectin‐dependent cell‐mediated cytotoxicity.
📜 SIMILAR VOLUMES
## Abstract Studies were performed to characterize the effector cells responsible for natural cytotoxicity of mouse lymphoid cells against a variety of syngeneic and allogeneic tumor lines. Since spleen cells from normal nude mice were found to be highly cytotoxic, they were used for most of these
Blood lymphocyte subsets of various densities from 14 healthy donors and 25 patients with solid tumors were used in tests for cytotoxicity against allogeneic or autologous tumor cells. The allogeneic combinations comprised 36 tests on 28 tumors. In these the unmanipulated total lymphocyte population
## Abstract Lymphoid cells from many normal mice of a variety of inbred strains were found to have reactivity, in a ^51^Cr release cytotoxicity assay, against several syngeneic and allogeneic tumors. Very high reactivity was seen with effector cells from athymic nude mice, which was consistent with
## Abstract The growth of transplanted tumors was strongly inhibited in syngeneic Wistar King Aptekman (WKA) rats immunized with allogeneic tumor cells from Donryu rats. This phenomenon of non‐specific immunity against tumors is referred to as “allogeneic cell immunity”. However, an exception to th
## Abstract Freshly separated tumor cells from sarcomas and carcinomas were used in various roles in lymphocyte‐target cell interaction assays. They were poorer allogeneic stimulators than lymphocytes. They were however good allotargets for the cytotoxicity generated in mixed lymphocyte cultures. T